Skip to main content
Log in

Serial immunological testing in patients with gastric cancer

  • Original Papers
  • Clinical Oncology or Epidemiology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Summary

Standard immunological parameters measuring non-specific cellular immune reactivity were determined in 175 patients with different stages of gastric cancer prior to surgery and during follow-up. Several tests measuring monocyte activity were also employed. The total number of T cells and their subpopulations Ta and T29° was unchanged except depression of T29° in stage IV. The blastogenic response of lymphocytes to PHA as assessed by stimulation of protein synthesis was only depressed in stage IV. In contrast the PHA-induced lymphokine production was increased in all patients but the differences were significant for stage III and IV. Monocyte Fc receptor expression was increased in stages II-IV, while nitro blue tetrazolium reduction and antibody dependent cellular cytotoxicity of monocytes was elevated in stage IV. The number of extractable monocytes was not increased. Longitudinal studies suggested that most of the parameters normalized during follow-up. No major long-term impact of chemoimmunotherapy (5-FU+BCG) on the immune parameters was observed except a transient increase in PPD reactivity approximately 1 year after commencement of treatment. In patients with stage III gastric cancer the increased occurrence of suppressor cells (mostly monocytes) and elevated cytostatic activity of monocytes was associated with a longer survival while the increased lymphokine production and Fc receptor expression were seen in the group of patients succumbing earlier. We concluded that most of the changes in immune parameters were seen only in advanced disease and paradoxically disappeared in the course of disease. The determination of monocyte activity seems to be a sensitive indicator of immune system dearrangements in earlier stages of cancer and a useful prognostic factor in gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Adkinson HF Jr, Rosenberg SA, Terry WD (1974) Early detection of lymphocyte stimulation and mixed lymphocyte interaction in man with semimicro protein synthesis assay. J Immunol 112:1426–1436

    Google Scholar 

  2. Bianco C, Patrick R, Nussenzweig V (1970) A population of lymphocyte bearing membrane receptor for antigen-antibody-complement complexes. J Exp Med 132:702–708

    Google Scholar 

  3. Braun DP, Nisius S, Hollinshead A, Harris JE (1983) Serial immune testing in surgically resected lung cancer patients. Cancer Immunol Immunother 15:114–120

    Google Scholar 

  4. Cannon GB, Dean JH, Herberman RB (1980) Association of depressed lymphoproliferative responses to alloantigens with poor prognosis in patients with stage I lung cancer. Int J Cancer 26:9–17

    Google Scholar 

  5. Cannon GB, Dean JH, Herberman RB, Keels M, Alford C (1981) Lymphoproliferative responses to autologous tumour extracts as prognostic indicators in patients with resected breast cancer. Int J Cancer 27:131–138

    Google Scholar 

  6. Catalona WJ, Samplem WF, Chretien PB (1973) Lymphocyte reactivity in cancer patients. Correlation with tumour histology and clinical stage. Cancer 31:65–71

    Google Scholar 

  7. Elhilali MM, Britton S, Brosman, S, Fahey JL (1976) Critical evaluation of lymphocyte functions in urological cancer patients. Cancer Res 36:132–137

    Google Scholar 

  8. Evans JT, Goldrosen MH, Han T, Minowada J, Howell J, Mittelman A, Ming Chu T, Holyoke ED (1977) Cell mediated immune status of colon cancer patients. Cancer 40:2516–2525

    Google Scholar 

  9. Gatti RA, Good RA (1971) Occurrence of malignancy in immunodeficiency disease. A literature review. Cancer 28:89–98

    Google Scholar 

  10. Gehan EA (1965) A generalized Wilcoxon test for comparing arbitrarily singly censored samples. Biometrica 52:203–223

    Google Scholar 

  11. Gil J, Orlowski T, Nowakowski W, Ko HL, Roszkowski K, Roszkowski W, Szmigielski S, Pulverer G, Jeljaszewicz J (1980) Local immunotherapy of stomach and intestinal carcinoma by Propionibacterium granulosum. Dis Colon Rectum 23:536–542

    Google Scholar 

  12. Golub SH, Forsythe AB, Morton DL (1977) Sequential examination of lymphocyte proliferation capacity in patients with malignant melanoma receiving BCG immunotherapy. Int J Cancer 19:18–26

    Google Scholar 

  13. Hoover R, Fraumens JF (1973) Risk of cancer in renal transplant recipients. Lancet II:55–58

    Google Scholar 

  14. Jerrells TR, Dean JH, Richardson G, Cannon GB, Herberman RB (1979) Increased monocyte-mediated cytostasis of lymphoid cell lines in breast and lung cancer. Int J Cancer 23:768–776

    Google Scholar 

  15. Jondal M, Holm G, Wigzell H (1972) Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming non-immune rosettes with sheep red blood cells. J Exp Med 136:207–215

    Google Scholar 

  16. Kopersztych S, Rezkallah MT, Miki SS (1976) Cell mediated immunity in patients with carcinoma: correlation between clinical stage and immunocompetence. Cancer 38:1149–1154

    Google Scholar 

  17. Kowalczyk D, Zembala M (1978) Migration inhibition of T lymphocytes from human peripheral blood by specific antigen and lymphokines. Clin Exp Immunol 32:333–338

    Google Scholar 

  18. Kowalczyk D, Zembala M, Popiela T, Łabza H (1978) The in vitro migration inhibition of mononuclear cells in patients with colorectal carcinoma. Arch Immunol Ther Exp (Warsz.) 26:435–439

    Google Scholar 

  19. Kowalczyk D, Zembala M, Ruggiero I (1985) Monocyte regulation of lymphokine production in cancer patients. J Clin Lab Immunol (in press)

  20. Mantovani A, Tagliabue A, Dean JH, Jerrells TR, Herberman RB (1979) Cytolytic activity of human monocytes on transformed and untransformed human fibroblasts. Int J Cancer 23:28–31

    Google Scholar 

  21. Manual for Staging of Cancer (1977) American Joint Committe for Cancer Staging and End-Results Reporting. AJCCS, Chicago

  22. Moertel CG, Ritts RE, O'Connell MJ, Silvers A (1979) Nonspecific immune determinants in patients with unresectable gastrointestinal carcinoma. Cancer 43:1483–1492

    Google Scholar 

  23. Mytar B, Zembala M, Uracz W, Czupryna A (1982) Cytostatic activity on tumour cells of monocytes from patients with gastrointestinal cancer. Cancer Immunol Immunother 130:190–193

    Google Scholar 

  24. Neilan BA (1980) Lack of correlation of T and B lymphocytes with stage of colorectal carcinoma. Dis Colon Rectum 23:65–67

    Google Scholar 

  25. O'Neill B Jr (1970) Monocytosis in malignant disease. Ann Int Med 73:991–992

    Google Scholar 

  26. Nordman E, Saarimaa H, Toivanen A (1978) The influence of 5-fluorouracil on cellular and humoral immunity in cancer patients. Cancer 41:64–69

    Google Scholar 

  27. Nyholm RE, Currie GA (1978) Monocytes and macrophages in malignant melanoma. II. Lysis of antibody-coated human erythrocytes as an assay of monocyte function. Br J Cancer 37:337–344

    Google Scholar 

  28. den Oetter W, Dullens HFJ, de Weger RA (1983) Macrophages and antitumour reactions. Cancer Immunol Immunother 16:67–71

    Google Scholar 

  29. Oldham RK, Gail MH, Baker MA, Forbes JT, Heineman W, Hersh E, Holmes EC, Ritts RE, Wright PW and Lung Cancer Study Group (1982) Immunological studies in double blind randomized trial comparing intrapleural BCG against placebo in patients with resected stage I non-small cell lung cancer. Cancer Immunol Immunother 13:164–173

    Google Scholar 

  30. Olkowski ZL, McLaren JR, Skeen MJ (1978) Effects of combined immunotherapy with Levamisole and Bacillus Calmette-Guerin on immunocompetence of patients with squamous cell carcinoma of cervix, head and neck, and lung undergoing radiation therapy. Cancer Treat Rep 62:1651–1661

    Google Scholar 

  31. Popiela T, Zembala M, Oszacki J, Jedrychowski W (1982) A follow-up study on chemoimmunotherapy (5-Fluorouracil and BCG) in advanced gastric cancer. Cancer Immunol Immunother 13:182–184

    Google Scholar 

  32. Prehn RT (1971) Immunosurveillance, regeneration and oncogenesis. Prog Exp Tumor Res 14:1–11

    Google Scholar 

  33. Simo-Camps S, Anguera A, Ma Vich J, Vidal-Ribas A, Sala F, Sarrias R, Gumma J, Gri E, Ma Puigdollers J (1976) Immunological impairment in patients with non-lymphoid cancer. Cancer 37:724–728

    Google Scholar 

  34. Stein JA, Adler A, BenEfraim SH, Maor M (1976) Immunocompetence, immunosuppression and human breast cancer. I. An analysis of their relationship by known parameters of cell-mediated immunity in well defined clinical stages of disease. Cancer 38:1171–1187

    Google Scholar 

  35. Teasdale C, Hughes LE, Whitehead RH, Newcombe RG (1979) Factors effecting pretreatment immunocompetence in cancer patients. I. The effect of age, sex and ill health. II. The corrected effects of malignant disease. Cancer Immunol Immunother 6:89–99

    Google Scholar 

  36. Trejdosiewicz lk, Treydosiewicz AJ, Ling NR, Dykes PW (1979) Growth enhancing property of human monocytes from normal donors and cancer patients. Immunology 37:247–252

    Google Scholar 

  37. Unger SW, Bernhard MJ, Pace RC, Wanebo HJ (1983) Monocyte dysfunction in human cancer. Cancer 51:669–674

    Google Scholar 

  38. Uracz W, Pituch-Noworolska A, Zembala M, Popiela T, Czupryna A (1982a) “Activated” monocytes in gastric cancer patients. I. Increased Fc receptor expression, antibody-dependent cellular cytotoxicity and NBT reduction. J Cancer Res Clin Oncol 104:181–190

    Google Scholar 

  39. Uracz M, Mytar B, Zembala M, Ruggiero I, Popiela T, Czupryna A (1982b) “Activated” monocytes in gastric cancer patients. II. Suppressor and cytostatic activity in vitro. J Cancer Res Clin Oncol 104:307–313

    Google Scholar 

  40. Waldman RH, Ganguly R, Cusumano CL (1978) Spontaneous MIF secretion by peripheral lymphocytes of cancer patients. J RES 23:335–341

    Google Scholar 

  41. Wanebo HJ, Rao B, Attiyeh F, Pinsky C, Middleman P, Stearns M (1980) Immune reactivity in patients with colorectal cancer: Assessment of biologic risk by immune parameters. Cancer 45:1254–1263

    Google Scholar 

  42. West WH, Sienknecht CW, Townes AS, Herberman RB (1976) Performance of a rosette assay between lymphocyte and sheep erythrozyte at elevated temperatures to study patients with cancer and other diseases. Clin Immunol Immunopathol 5:60–66

    Google Scholar 

  43. Wybran J, Fudenberg HH (1973) Thymus derived rosette forming cells in various disease states: cancer, lymphoma, bacterial and viral infections and other diseases. J Clin Invest 52:1026–1032

    Google Scholar 

  44. Zembala M (1981) Tests for monocyte function in human disease. Clin Immunol Allergy 1:543–560

    Google Scholar 

  45. Zembala M, Mytar B, Ruggiero I, Uracz W, Popiela T, Czupryna A (1983) Suppressor cells and survival of patients with advanced gastric cancer. J Natl Cancer Inst 70:223–228

    Google Scholar 

  46. Zembala M, Uracz W, Ruggiero I, Mytar B, Pryjma J (1984) Isolation and functional characteristics of FcR+and FcR-human monocyte subsets. J Immunol 133:1293–1299

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zembala, M., Popiela, T., Kowalczyk, D. et al. Serial immunological testing in patients with gastric cancer. J Cancer Res Clin Oncol 111, 62–70 (1986). https://doi.org/10.1007/BF00402779

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00402779

Key words

Navigation